JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 1 filers reported holding JANUX THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,444,704 | -0.7% | 3,317,927 | +17.0% | 0.71% | +16.4% |
| Q2 2023 | $33,667,902 | -1.9% | 2,836,386 | 0.0% | 0.61% | -9.5% |
| Q1 2023 | $34,320,271 | -8.1% | 2,836,386 | 0.0% | 0.67% | -5.7% |
| Q4 2022 | $37,355,204 | -2.7% | 2,836,386 | 0.0% | 0.72% | +0.3% |
| Q3 2022 | $38,405,000 | +10.9% | 2,836,386 | 0.0% | 0.71% | +13.5% |
| Q2 2022 | $34,632,000 | -14.9% | 2,836,386 | 0.0% | 0.63% | -4.8% |
| Q1 2022 | $40,674,000 | -27.3% | 2,836,386 | 0.0% | 0.66% | -8.2% |
| Q4 2021 | $55,962,000 | -25.4% | 2,836,386 | -18.2% | 0.72% | -12.7% |
| Q3 2021 | $74,978,000 | -13.3% | 3,466,386 | 0.0% | 0.82% | -5.8% |
| Q2 2021 | $86,486,000 | – | 3,466,386 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $216,333,000 | 3.47% |
| 5AM Venture Management, LLC | 446,266 | $11,134,000 | 2.80% |
| Samsara BioCapital, LLC | 607,949 | $15,168,000 | 1.87% |
| EcoR1 Capital, LLC | 1,411,975 | $35,229,000 | 1.32% |
| Logos Global Management LP | 547,122 | $13,651,000 | 1.15% |
| BVF INC/IL | 1,176,681 | $29,358,000 | 1.10% |
| Orbimed Advisors | 3,466,386 | $86,486,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 700,000 | $17,465,000 | 0.31% |
| Pinz Capital Management, LP | 32,100 | $801,000 | 0.24% |
| Woodline Partners LP | 334,260 | $8,340,000 | 0.16% |